XML 11 R2.htm IDEA: XBRL DOCUMENT v3.25.4
Unaudited Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2025
Dec. 31, 2024
Current Assets:    
Cash $ 25 $ 4,637
Other current assets 48,025
Total Current Assets 48,050 4,637
Investments held in the Trust Account 42,361,047 48,084,367
Cash in transit to Trust Account 172,500 345,000
Total Assets 42,581,597 48,434,004
Current liabilities:    
Accrued expenses and other payable 2,362,065 1,606,632
Deposit from the target company 330,969 330,969
Total Current Liabilities 6,554,934 4,392,751
Derivative warrant liability – private warrant 10,300 17,000
Deferred underwriting commission 2,012,500 2,012,500
Total Liabilities 8,577,734 6,422,251
COMMITMENTS AND CONTINGENCIES (Note 6)
Shareholders’ Deficit:    
Preferred shares, $0.0001 par value, 5,000,000 shares authorized, none issued and outstanding as of June 30, 2025 and December 31, 2024
Accumulated deficit (8,357,362) (6,417,792)
Total Shareholders’ Deficit (8,357,184) (6,417,614)
Total Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit 42,581,597 48,434,004
Class A Ordinary Shares    
Current liabilities:    
Class A ordinary shares subject to possible redemption, $0.0001 par value; 500,000,000 shares authorized; 3,577,425 and 4,257,354 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively 42,361,047 48,429,367
Shareholders’ Deficit:    
Ordinary shares 34 34
Class B Ordinary Shares    
Shareholders’ Deficit:    
Ordinary shares 144 144
Related Party    
Current liabilities:    
Due to a related party 270,000 210,000
Promissory notes – a related party $ 3,591,900 $ 2,245,150